Burcu B. Gulbagcı
Tekirdag, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.
Journal: Immunotherapy
Published: September 02, 2026
Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study.
Journal: Journal of bone oncology
Published: June 12, 2026
Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.
Journal: BMC cancer
Published: March 31, 2026
Short-Term Biceps Muscle Wasting Assessed by Serial Ultrasound as a Predictor of Survival Duration in Terminally Ill Cancer Patients: A Retrospective Cohort Study.
Journal: Medicina (Kaunas, Lithuania)
Published: December 11, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Journal: Future oncology (London, England)
Published: October 17, 2025
Relationship Between Netrin-1 Staining and Neoadjuvant Treatment Response in HER2-Positive Locally Advanced Breast Cancer.
Journal: Cancer management and research
Published: October 08, 2025
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Journal: Scientific reports
Published: March 19, 2025
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
Journal: BMC cancer
Published: August 03, 2024
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: June 29, 2024
Last Updated: 09/26/2026